Volume 156, Pages 163-167 (August 2017) Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation

Slides:

Advertisements

Similar presentations

Speciation by symbiosis Robert M. Brucker, Seth R. Bordenstein Trends in Ecology & Evolution Volume 27, Issue 8, Pages (August 2012) DOI: /j.tree

Advertisements

Ancient Endo-siRNA Pathways Reveal New Tricks Julie M. Claycomb Current Biology Volume 24, Issue 15, Pages R703-R715 (August 2014) DOI: /j.cub

Atrial Fibrillation and Heart Failure Andrew A. Grace, MB, PhD, FRCP Heart Failure Clinics Volume 9, Issue 4, (October 2013) DOI: /j.hfc

Global Burden of Atrial Fibrillation in Developed and Developing Nations Sumeet S. Chugh, Gregory A. Roth, Richard F. Gillum, George A. Mensah Global Heart.

Perimenopausal migraine in women with vasomotor symptoms E. Anne MacGregor Maturitas Volume 71, Issue 1, Pages (January 2012) DOI: /j.maturitas

The most efficient STR loci in forensic genetics in population of central Poland R. Jacewicz, M. Jedrzejczyk, J. Berent Forensic Science International:

Prognosis and disease progression in patients under 50 years old undergoing PCI: The CRAGS (Coronary aRtery diseAse in younG adultS) study Anna Lautamäki,

Volume 370, Issue 9586, Pages (August 2007)

Volume 134, Issue 3, Pages (September 2014)

The relationship between childhood adversities and fibromyalgia in the general population Aleksi Varinen, Elise Kosunen, Kari Mattila, Tuomas Koskela,

Volume 130, Issue 5, Pages (November 2012)

The relationship between maintenance dosages of three vitamin K antagonists: Acenocoumarol, warfarin and phenprocoumon Yvonne van Leeuwen, Frits R. Rosendaal,

Volume 48, Issue 10, Pages (October 2017)

Usefulness of Outpatient Bleeding Risk Index to Predict Bleeding Complications in Patients With Long-term Oral Anticoagulation Undergoing Coronary Stenting

Volume 116, Issue 6, Pages (January 2005)

Volume 136, Issue 4, Pages (October 2015)

Hortensia De la Corte-Rodriguez, E. Carlos Rodriguez-Merchan

Ambulatory Blood Pressure Monitoring in Atrial Fibrillation

Ted Klok, Adrian A. Kaptein, Eric J. Duiverman, Paul L. Brand

Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: A systematic review of the literature Omar Abdel-Rahman,

Sarah Caton, Elly O'Brien, Annie Jullien Pannelay, Robert G. Cook

Maros Ferencik, Yiannis S. Chatzizisis Atherosclerosis

The longitudinal association between homelessness, injection drug use, and injection- related risk behavior among persons with a history of injection drug.

A peculiar medical cardioversion of atrial fibrillation with glucose infusion—a rare cause of atrial fibrillation: hypoglycemia Savas Celebi, MD The.

Volume 16, Issue 2, Pages (August 2009)

Incidence and risk factors of postpericardiotomy syndrome requiring medical attention: The Finland postpericardiotomy syndrome study Joonas Lehto, BM,

Thank God for Richard Dawkins?

Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal Gregory.

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study Torben Bjerregaard Larsen, MD,

Recurrent thromboembolism in patients with vena cava filters

Volume 137, Issue 2, Pages (February 2010)

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study Torben Bjerregaard Larsen, MD,

Integrating osteopathic approaches based on biopsychosocial therapeutic mechanisms. Part 1: The mechanisms Gary Fryer, B.Sc.(Osteopathy), Ph.D. International.

Radiological incidence of parastomal herniation in cancer patients with permanent colostomy: What is the ideal size of the surgical aperture? Alexander.

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation Pilar Gallego, MD, PhD, Vanessa Roldán,

Symptomatic venous thromboembolism after femoral vein harvest

Aspirin in the prevention of cancer – Author's reply

Deep venous thrombosis after repair of nonruptured abdominal aneurysm

Gregory Y.H. Lip, MD, Jonathan L. Halperin, MD, Hung-Fat Tse, MD, PhD

What does STOP-2 tell us about management of hypertension?

In This Issue Cell Volume 158, Issue 5, (August 2014)

International normalized ratio and prothrombin time values before the removal of a lumbar plexus catheter in patients receiving warfarin after total hip.

A Patient Has a 3-Centimeter Cecal Polyp on Chronic Anticoagulation for a Mechanical Mitral Valve Prosthesis Andrew J. Overhiser, Douglas K. Rex Clinical.

Truman J. Milling, MD, Alex C. Spyropoulos, MD

Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin Keitaro Senoo, MD, Marco Proietti,

James L. Cox, MD, Niv Ad, MD, Terry Palazzo, RN, MS

Isla M. Ogilvie, PhD, Nick Newton, PhD, Sharon A

Symptomatic perioperative venous thromboembolism is a frequent complication in patients with a history of deep vein thrombosis Timothy K. Liem, MD, Thanh.

Large scale analysis of HCM mutations in sudden cardiac death

Changing axis deviation, paroxysmal atrial fibrillation and elevation of prostate-specific antigen during acute myocardial infarction Salvatore Patanè,

Optimizing Atrial Fibrillation Management

Clinical importance of short–long–short sequences: Analysing the mode of onset of ventricular tachycardias and atrial fibrillation Bulent Gorenek International.

Confessions of a journal junkie

Recurrent thromboembolism in patients with vena cava filters

Atrial fibrillation: Improvement in identification and stroke preventive therapy —Data from the UK Clinical Practice Research Datalink, 2000–2012 A.C.E.

Telling it like it isn't: truth and lies in a post-9/11 world

Risk Factors for Atrial Fibrillation After Lung Cancer Surgery: Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database Mark Onaitis,

Thank God for Richard Dawkins?

Screening for atrial fibrillation in general practice: A national, cross-sectional study of an innovative technology Gerard Bury, Davina Swan, Walter.

Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study Harry J.G.M. Crijns, Bob Weijs, Anna-Meagan.

Application of less primer method to commercial kits

Increasing incidence of brain tumours in sparsely populated areas

Yoko Miyasaka, MD, PhD, Marion E. Barnes, MSc, Bernard J

Difficult intubation in obese patients: incidence, risk factors, and complications in the operating theatre and in intensive care units A. De Jong, N.

The American Journal of Medicine

Clive Kearon, Michael J Kovacs, Jim A Julian

Right bundle branch block with revelation of changing axis deviation at the end of atrial fibrillation Salvatore Patanè, Filippo Marte, Mauro Sturiale

Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation Finlay A. McAlister,

Left atrial appendage flow during atrial fibrillation, as determined by pulsed Doppler during transoesophageal echocardiography. Left atrial appendage.

Deep venous thrombosis after repair of nonruptured abdominal aneurysm

Presentation transcript:

Volume 156, Pages 163-167 (August 2017) Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation Tapio Hellman, Tuomas Kiviniemi, Ilpo Nuotio, Tuija Vasankari, Juha Hartikainen, Gregory Y.H. Lip, K.E. Juhani Airaksinen Thrombosis Research Volume 156, Pages 163-167 (August 2017) DOI: 10.1016/j.thromres.2017.06.026 Copyright © 2017 Elsevier Ltd Terms and Conditions

Fig. 1 Flow chart illustrating patient selection in the study. AF=atrial fibrillation; ECV=elective cardioversion. Thrombosis Research 2017 156, 163-167DOI: (10.1016/j.thromres.2017.06.026) Copyright © 2017 Elsevier Ltd Terms and Conditions

Fig. 2 Incidence of thromboembolic events in patients with high (≥2.5) therapeutic INRs (full color) compared to those with low (2.0–2.4) therapeutic INRs (no color) at elective cardioversion (ECV) (Panel A), and in patients with therapeutic (≥2.0) vs. subtherapeutic (<2.0) INRs within 21days after ECV (Panel B). Thrombosis Research 2017 156, 163-167DOI: (10.1016/j.thromres.2017.06.026) Copyright © 2017 Elsevier Ltd Terms and Conditions